Hot Deals:
amol minechem 601.00 (0.17 %) anglo french drugs 930.00 (3.33 %) anugraha valve 280.00 (1.82 %) apl metals 40.00 (-2.44 %) apollo fashion 107.00 (1.90 %) archit nuwood 500.00 arkfin investments 50.00 arohan 202.00 (1.00 %) assam carbon 265.00 (1.92 %) avalokiteshvar 242.00 (0.83 %) axles india 610.00 (1.67 %) balmer lawrie 202.00 (1.00 %) bharat hotels 345.00 (1.47 %) bima mandi 235.00 (-2.08 %) bira 555.00 (-0.89 %) boat 1,380.00 (-1.43 %) c & s electric 840.00 (-1.18 %) cable corporation 13.00 (-0.76 %) capgemini 11,900.00 (0.85 %) care health 186.00 (-1.59 %) carrier aircon 545.00 (-0.91 %) cial 326.00 (0.31 %) csk 170.00 (-1.16 %) dalmia refract 260.00 (1.96 %) dfm foods 467.00 dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 440.00 (3.53 %) electronica plastic 2,100.00 (-0.99 %) elgi ultra 400.00 elofic 2,100.00 (2.44 %) esl steel 46.00 (1.10 %) fincare business 86.00 (3.61 %) fincare sfbl 205.00 (1.49 %) fino paytech 133.00 (-1.48 %) flipkart india 231,001.00 (0.00 %) frick india 15,600.00 (-0.95 %) gkn driveline 1,325.00 (-0.38 %) godavari bio 71.00 (1.43 %) goodluck defence 235.00 (2.17 %) group pharma 300.00 gynofem healthcare 63.00 (-3.08 %) hazira cargo terminals limited 205.00 (1.49 %) hdb financial 1,120.00 (-0.88 %) hdfc ergo 370.00 (1.70 %) hdfc securities 11,300.00 (-1.74 %) hella india 910.00 (1.11 %) hero fincorp 1,990.00 (-0.50 %) hexaware 720.00 (-2.70 %) hicks 1,450.00 (2.11 %) hira ferro 180.00 (2.86 %) honeywell electrical 6,200.00 (1.64 %) ikf finance 312.00 (0.65 %) incred financial 10.00 (1.01 %) incred holdings 165.00 (-1.79 %) india carbon 1,135.00 (-1.30 %) india exposition 121.00 (0.83 %) indian potash 3,250.00 (1.56 %) indian seamless 175.00 (2.94 %) indo alusys 25.75 (-0.96 %) indofil 1,030.00 (0.49 %) infinite computer 405.00 (1.25 %) inkel 29.00 (-3.33 %) jana small finance bank 75.00 kel 610.00 (-2.40 %) kial 126.00 (-1.56 %) klm axiva 15.75 (1.61 %) kurlon limited 1,255.00 (0.40 %) lava 49.00 (-2.00 %) mahindra rural mrhfl 100.00 manipal housing 74.00 (2.07 %) manjushree technopack 3,050.00 (0.66 %) martin & harris 975.00 (-1.52 %) matrix gas 950.00 (-1.04 %) merino 3,350.00 (1.52 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 410.00 (-2.38 %) mobikwik 595.00 (-0.34 %) mohan meakin 2,150.00 (2.38 %) mohfl 13.60 (-0.73 %) msei 1.15 (-0.86 %) msil 36.00 (2.86 %) nayara energy 595.00 (-0.83 %) nayara energy ncd 315.00 (3.28 %) ncdex 220.00 (-0.90 %) ncl buildtek 310.00 (3.33 %) ncl holdings 92.00 (1.10 %) northern arc 400.00 nsdl 825.00 (1.85 %) nse 5,700.00 (1.79 %) orbis financial 340.00 (0.29 %) oswal minerals 60.10 (-1.48 %) otis 3,700.00 (-0.67 %) oyo 43.50 (-1.14 %) panasonic appliances 262.00 (0.77 %) paymate india 520.00 (-0.95 %) pharmeasy 8.50 (-2.30 %) pharmed limited 480.00 (2.13 %) philips domestic 720.00 (-1.37 %) philips india 910.00 (-1.09 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 255.00 (-1.92 %) rapido 16,650.00 (0.03 %) rasoi 31,500.00 (0.32 %) reliance gic 505.00 (1.00 %) resins plastics 475.00 (3.26 %) ring plus aqua 530.00 (0.95 %) rrl 1,275.00 (2.00 %) rrp s4e innovation 345.00 (-1.43 %) sab miller 490.00 (2.94 %) sbi amc 2,150.00 (0.94 %) sbi general insurance 620.00 (3.33 %) scottish assam 480.00 (2.13 %) shriram life 261.00 (0.38 %) sigachi laboratories 36.00 (-2.70 %) signify 1,330.00 (-0.75 %) smile microfinance 55.00 (1.85 %) sterlite power 748.00 (-0.27 %) studds 915.00 (-1.08 %) svsml 315.00 (2.94 %) swiggy 355.00 (1.43 %) t stanes 810.00 (1.25 %) tata capital 1,040.00 (-0.95 %) teesta agro 77.00 (-6.21 %) trl krosaki 1,300.00 (1.96 %) urban tots 92.00 (2.22 %) utkarsh coreinvest 310.00 (3.33 %) vadilal dairy 10.00 vikram solar 285.00 (-1.72 %) vivriti capital 1,150.00 (-0.86 %) waree energies 2,150.00 (-0.46 %)
×

Jagadishwar Annual Reports, Balance Sheet and Financials

Jagadishwar Pharmaceuticals Works Limited (Jagadishwar Pharma) Return Comparision with Primex 40 Index

Periods 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years All Time
Primex-40
Jagadishwar Pharmaceuticals Works Limited

 Jagadishwar Pharmaceutical Works Limited Balance Sheet (Rs In rs.)

Particulars

31-03-2022

31-03-2021

Assets

 

 

Non-Current Assets

 

 

Investments

    12,95,94,147.54

130230881.07

Other Non-Current Assets

415021.00

247369.00

Current Assets

 

 

Inventories

4,30,28,802.04

4,29,09,773.80

Cash and Cash Equivalents

64,70,981.65

8,30,259.57

Loans

4,76,97,794.00

7,17,82,439.00

Other Current Assets

8,13,72,287.40

6,22,77,287.40

Total Assets

 30,85,79,033.63

308278009.84

Equity & Liabilities

 

 

Equity

 

 

Share Capital

29,70,01,900.00

297001900.00

Other Equity

1,15,67,373.63

1,12,66,349.84

Liabilities

 

 

Current Liabilities

 

 

Other Liabilities

9,760.00

9,760.00

Total Equity and Liabilities

30,85,79,033.63

308278009.84

Jagadishwar Pharmaceutical Works Limited Profit & Loss Statement (Rs In rs.)

Particulars

31-03-2022

31-03-2021

Revenue from operations

1,84,500.00

3,50,80,085.00

Other income

50,61,221.00

56,59,916.00

Total Income

52,45,721.00

4,07,40,001.00

Purchase

3,03,528.00

5,38,720.00

Changes in inventory of Finished Goods

-1,19,028.24

3,64,11,570.00

Employee benefit expenses

20,19,188.00

15,19,490.00

Other expenses

17,65,805.92

10,32,903.00

Total expenses

39,69,493.68

3,95,02,683.00

Profit before tax

12,76,227.32

12,37,318.00

Tax Expense for Current Year

3,38,470.00

3,35,360.00

Profit/(loss) for the year

9,37,757.32

9,01,958.00

Items that will not be reclassified to profit or loss-Actuarial (Loss)/Gain

-6,36,733.53

4,35,090.02

Other Comprehensive Income

-6,36,733.53

4,35,090.02

Total Comprehensive Income for the Year

3,01,023.79

13,37,048.02

Earnings per Equity Share

 

 

Basic and Diluted

0.38

0.03

Jagadishwar Pharmaceutical Works Limited Consolidated Cash Flow Statement (Rs In rs.)

Particulars

31-03-2022

31-03-2021

Cash flows from operating activities

 

 

Net Profit/(loss) before Taxation

12,76,227.32

12,37,318.00

Adjustments for:

-

-

Interest income

-50,61,221.00

-56,59,916.00

Operating profit before working capital changes

-37,84,993.68

-44,22,598.00

Adjustment for :

 

 

Change in Inventories

-119028.24

36411570

Change in Other Current Liabilities

-

-2,740.00

Change in Financial Loans

24084645

-4,52,76,440.00

Change in Other Current Assets

-1,90,95,000.00

-3,39,50,000.00

Changes in working capital

48,70,616.76

-42817610.00

Cash Generated from Operations

10,85,623.08

-47240208.00

Income Tax Paid

-5,06,122.00

-356859.00

Net cash from operating activities

5,79,501.08

-47597067.00

Cash flows from investing activities

-

-

- Adjustment for :-

 

 

Non Current Financial Assets

-

42204520.5

Interest Income

5061221

5659916

Net cash generated by investing activities

5061221.00

47864436.50

Net increase/(decrease) in cash and cash equivalents

56,40,722.08

267369.50

Cash and cash equivalents at the beginning of the year

830259.57

562890.07

Cash and cash equivalents at the end of the year

64,70,981.65

830259.57

 

Here is a summary of the Cash Flow Statement for the years 2022 and 2021:

Operating Activities:

Net Profit Before Taxation: The net profit before taxation increased from 12,37,318.00 in 2021 to 12,76,227.32 in 2022, indicating improved profitability.

Interest Income: There was a significant decrease in interest income from -56,59,916.00 in 2021 to -50,61,221.00 in 2022.

Operating Profit Before Working Capital Changes: There was a decrease in operating profit before working capital changes from -44,22,598.00 in 2021 to -37,84,993.68 in 2022.

Changes in Working Capital: There was a positive change in working capital, with cash generated from operations increasing from -4,72,40,208.00 in 2021 to 10,85,623.08 in 2022.

Income Tax Paid: Income tax paid increased from -3,56,859.00 in 2021 to -5,06,122.00 in 2022.

Investing Activities:

There is no information provided for investing activities in both years.

Cash and Cash Equivalents:

Net Increase/(Decrease) in Cash: The net increase in cash and cash equivalents was significant, rising from 2,67,369.50 in 2021 to 56,40,722.08 in 2022.

Cash and Cash Equivalents at the Beginning and End of the Year: The cash and cash equivalents at the beginning of the year were 5,62,890.07 in 2021 and increased to 8,30,259.57 in 2022. By the end of the year, cash and cash equivalents rose to 64,70,981.65 in 2022 from 8,30,259.57 in 2021.

In summary, in 2022, the company experienced improved profitability with an increase in net profit before taxation. Despite a decrease in interest income and operating profit before working capital changes, there was a positive change in working capital, resulting in cash generated from operations. This led to a significant increase in cash and cash equivalents compared to the previous year. Additionally, there were no significant investing activities reported for both years.

Financial Ratios: N/A

Dividend History of Jagadishwar Pharmaceutical Works Limited

PARTICULARS

2022

2021

Dividend Per Share

-

-

Retained Earnings (In Rs.)

47,42,454.09

38,04,696.77

Annual Report

Jagadishwar Pharmaceuticals Annual Report 2021-22

Download
Wealth Wisdom - WWIPL
Support Megha Support Neha

News Alert